These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36293087)

  • 1. Components of the Complement Cascade Differ in Polycystic Ovary Syndrome.
    Butler AE; Moin ASM; Sathyapalan T; Atkin SL
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classical and alternate complement factor overexpression in non-obese weight matched women with polycystic ovary syndrome does not correlate with vitamin D.
    Moin ASM; Sathyapalan T; Butler AE; Atkin SL
    Front Endocrinol (Lausanne); 2022; 13():935750. PubMed ID: 36619572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation in polycystic ovary syndrome occurs in the postprandial and fasted state and is influenced by obesity and insulin sensitivity.
    Lewis RD; Narayanaswamy AK; Farewell D; Rees DA
    Clin Endocrinol (Oxf); 2021 Jan; 94(1):74-84. PubMed ID: 32865246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Moderate Aerobic Exercise on Complement Activation Pathways in Polycystic Ovary Syndrome Women.
    Ramanjaneya M; Abdalhakam I; Bettahi I; Bensila M; Jerobin J; Aye MM; Alkasem M; Sathyapalan T; Atkin SL; Abou-Samra AB
    Front Endocrinol (Lausanne); 2021; 12():740703. PubMed ID: 35250845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products.
    Farries TC; Lachmann PJ; Harrison RA
    Biochem J; 1988 May; 252(1):47-54. PubMed ID: 3421908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated Adipsin and Reduced C5a Levels in the Maternal Serum and Follicular Fluid During Implantation Are Associated With Successful Pregnancy in Obese Women.
    Ramanjaneya M; Diboun I; Rizwana N; Dajani Y; Ahmed L; Butler AE; Almarzooqi TA; Shahata M; Al Bader MK; Elgassim E; Burjaq H; Atkin SL; Abou-Samra AB; Elrayess MA
    Front Endocrinol (Lausanne); 2022; 13():918320. PubMed ID: 35909516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decay-accelerating factor must bind both components of the complement alternative pathway C3 convertase to mediate efficient decay.
    Harris CL; Pettigrew DM; Lea SM; Morgan BP
    J Immunol; 2007 Jan; 178(1):352-9. PubMed ID: 17182573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The binding of human complement proteins C5, factor B, beta 1H and properdin to complement fragment C3b on zymosan.
    DiScipio RG
    Biochem J; 1981 Dec; 199(3):485-96. PubMed ID: 6462133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of C3b(2)--IgG complexes with complement proteins properdin, factor B and factor H: implications for amplification.
    Jelezarova E; Vogt A; Lutz HU
    Biochem J; 2000 Jul; 349(Pt 1):217-23. PubMed ID: 10861231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
    Ross GD; Newman SL; Lambris JD; Devery-Pocius JE; Cain JA; Lachmann PJ
    J Exp Med; 1983 Aug; 158(2):334-52. PubMed ID: 6224880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences between the binding sites of the complement regulatory proteins DAF, CR1, and factor H on C3 convertases.
    Pangburn MK
    J Immunol; 1986 Mar; 136(6):2216-21. PubMed ID: 2419425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice.
    Miwa T; Sato S; Gullipalli D; Nangaku M; Song WC
    J Immunol; 2013 Apr; 190(7):3552-9. PubMed ID: 23427256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of complement-dependent haemolysis via the lectin pathway: role of the complement regulatory proteins.
    Suankratay C; Mold C; Zhang Y; Lint TF; Gewurz H
    Clin Exp Immunol; 1999 Sep; 117(3):442-8. PubMed ID: 10469045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human complement proteins C3b, C4b, factor H and properdin react with specific sites in gp120 and gp41, the envelope proteins of HIV-1.
    Stoiber H; Schneider R; Janatova J; Dierich MP
    Immunobiology; 1995 Jun; 193(1):98-113. PubMed ID: 7590866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual hemolytic and proteolytic activity expressed by Bb after decay-dissociation of C3b,Bb.
    Fishelson Z; Müller-Eberhard HJ
    J Immunol; 1984 Mar; 132(3):1425-9. PubMed ID: 6229580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement alternative pathway activation in human nonalcoholic steatohepatitis.
    Segers FM; Verdam FJ; de Jonge C; Boonen B; Driessen A; Shiri-Sverdlov R; Bouvy ND; Greve JW; Buurman WA; Rensen SS
    PLoS One; 2014; 9(10):e110053. PubMed ID: 25299043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus glycoprotein C: molecular mimicry of complement regulatory proteins by a viral protein.
    Huemer HP; Wang Y; Garred P; Koistinen V; Oppermann S
    Immunology; 1993 Aug; 79(4):639-47. PubMed ID: 8406590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement profile in microscopic polyangiitis and granulomatosis with polyangiitis: analysis using sera from a nationwide prospective cohort study.
    Fukui S; Ichinose K; Sada KE; Miyamoto J; Harigai M; Amano K; Atsumi T; Takasaki Y; Dobashi H; Arimura Y; Hasegawa H; Yuzawa Y; Yamagata K; Tsuboi N; Maruyama S; Matsuo S; Makino H; Maeda T; Kawakami A
    Scand J Rheumatol; 2020 Jul; 49(4):301-311. PubMed ID: 32286129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDL-Associated Proteins in Subjects with Polycystic Ovary Syndrome: A Proteomic Study.
    Butler AE; Moin ASM; Reiner Ž; Sathyapalan T; Jamialahmadi T; Sahebkar A; Atkin SL
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complement.
    Farries TC; Lachmann PJ; Harrison RA
    Biochem J; 1988 Aug; 253(3):667-75. PubMed ID: 3140783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.